Genetic Crop Design Company Evogene Sets Up Agricultural Biology Subsidiary

Nasdaq and Tel Aviv-listed genetic crops design company Evogene Ltd. announced Tuesday the establishment of new agricultural biology subsidiary LaVie Bio Ltd. In a statement, Evogene said that LaVie will focus on the fields of food quality and agricultural sustainability and productivity, through the introduction of microbiome-based ag-biological products.

For daily updates, subscribe to our newsletter by clicking here.

  

Evogene uses computational predictive biology to develop novel crop strains and pesticides, in a variety of related domains, including agricultural chemicals, agricultural biological, and human microbiome-based therapeutics.

Evogene launched its ag-biologicals division in 2015. Ido Dor, previously general manager of Evogene’s ag-biologicals division, was appointed CEO of LaVie. Ofer Haviv, Evogene's CEO, will serve as chairman of the board of directors of the new subsidiary.